Global Marine Biotechnology Industry

• Publication date: April 2012
• Report size: 295 pages

This report analyzes the Global markets for Marine Biotechnology in US$ Million by the following Product Segments: Marine Biomaterials, Marine Bioactive Substances, and Others. The major End-Use Applications analyzed are Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services & Infrastructure, and Others. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is ...

This report analyzes the Global markets for Marine Biotechnology in US$ Million by the following Product Segments: Marine Biomaterials, Marine Bioactive Substances, and Others. The major End-Use Applications analyzed are Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services & Infrastructure, and Others. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for this market. The report profiles 87 companies including many key and niche players such as Aker BioMarine ASA, Ashland Inc., CP Kelco US, Inc., Cyanotech Corp., Elan Corp, FMC Corp., FMC Biopolymers AS, GlycoMar Ltd., Lonza Group Ltd., MariCal, Marinova, Mera Pharmaceuticals Inc., New England Biolabs Inc., PharmaMar S.A, PML Applications Ltd., Prolume Ltd., Royal DSM N.V, Sea Run Holdings Inc., and Tequesta Marine Biosciences. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Global Biotechnology Industry

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability And Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-3
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
By Product Segment I-3
Biomaterials I-3
Bioactive Substances I-3
Others I-3
By End-Use Application I-4
Industrial Products I-4
Health Care/Biotechnology I-4
Consumer Products I-4
Public Services And Infrastructure I-4
Others I-4


II. EXECUTIVE SUMMARY

1. INDUSTRY DYNAMICS II-1
A Quick Primer II-1
Market Scorecard II-2
Impact of Europe’s Debt Crisis: A Review II-2
Trends and Issues II-3
Recession Impacts Biotechnology Market II-3
Medical, Food and Cosmetic Sectors Garner Research Dollars II-4
Lack of R&D Investment in the Marine Biotech Industry II-4
Preserving Marine Ecology: A Prime Concern II-5
A Glance at Marine Coatings Market II-5

2. MARINE BIOTECHNOLOGY - AN OVERVIEW II-6
A Curtain Raiser II-6
Why are Microorganisms Crucial? II-6
Brief History II-7
Definition II-7
Sources of Marine Biotech Products II-8
Key Marine Sources and Products II-8
Select Marine-Derived Products II-8
Flora and Fauna II-9
Protista II-9
Bacteria II-9
Fungi II-9
Types of Marine Biotech Products II-9
Marine Biomaterials II-10
Marine Adhesives II-10
Marine Bioactive Substances II-10
Select Biological Materials and Chemicals Extracted from
Marine Organisms II-11
Select Companies Involved in Supplying Reagents or
Nutritional Products from Marine Organisms II-13
Enzymes II-13
Haloperoxidase Enzymes II-13
Thermostable DNA-Modifying Enzymes II-13
Other Marine Products and Processes II-13
Marine Biomass II-13
Marine Bio-Process II-14
Certain Significant Bio-Processes and their Application II-14
End-Use Analysis II-14
Definition II-14
Industrial Products II-14
Health Care/Biotechnology II-15
Consumer Products II-15
Public Services and Infrastructure II-15
Others II-15
Overview II-15
Application Areas II-16
Foods II-16
Nutraceuticals II-16
Medicine II-16
Cosmetics II-16
Research Tools II-17
Processing Technologies II-17
New Energy Sources II-17
Agriculture II-17
Industrial II-17
Food Safety II-18
Environmental Management II-18
Bioremediation II-18
Marine Biosurfactants II-19
Select Biosurfactants Produced from Marine Microorganisms II-19
Aquaculture and Marine Biotechnology II-19
Select Companies Carrying Out Genetic Enhancement or
Aquaculture Breeding Programs II-20
Industrial Applications II-20
Healthcare II-20
Select Marine Diterpenes and Their Biological Activity II-21
Select Players Involved in Biosensor/Diagnostic Activity II-21
Select Marine-Based Drugs II-21
Cytosar-U II-21
Prialt II-21
Yondelis II-22
Bryostatin II-22
Dehydrodidemnin B II-22
Pseudopterosins II-22
Bio-Prospecting II-22
Select Companies Involved in Bioprospecting and
Bioscreening for Novel Marine-Based Compounds II-23
Consumer Products II-23
Select Macroalgal Materials and Their Application in
Cosmetic Industry II-23
Public Services and Infrastructure II-24
Others II-24
Agriculture II-24
Mining II-24
An Insight into Select Marine-Origin Products II-24
Agar II-24
Major Seaweeds Used for Extracting Agar and Agarose II-25
Alginate II-25
Astaxanthin II-26
Select Producers of Natural and Synthetic Astaxanthin II-26
Carrageenan II-26
Chitin and Chitosan II-27
Chitin II-27
End-use Applications II-27
Chitosan II-28
Select Industrial Applications of Chitosan II-29
Collagen II-29
Salmon Calcitonin II-30
Research and Development Activity II-30
Medical II-30
Research on Natural Products II-30
Tackling Biotoxins II-31
Controlling Oil Spill Damage II-31
Preventing Biofouling II-31
Antifouling Coatings II-31
Coral Reefs Offer Abundant Opportunities II-31

3. REGIONAL MARKET OVERVIEW II-33
The United States II-33
Overview II-33
Aquaculture Biotechnology II-33
Rest of World II-33
Australia II-33
Canada II-34
China II-34
Europe II-34
The United Kingdom II-35
Norway II-36
Overview II-36
Market Participants II-36
Industrial Applications II-36
Pharmaceuticals II-36
Latin America II-37
India II-37
Marine Environment Offers Abundant Opportunities for R&D
Initiatives II-37
Biotechnology Market in India on Growth Trajectory II-37
Market Participants II-38
Government Initiatives II-38
New Zealand II-38

4. PRODUCT INTRODUCTIONS/INNOVATIONS II-39
Aqua Bio Technology Launches Zonase X Marine Ingredient II-39
Frutarom USA to Introduce New Range of Marine Extracts II-39
Biotech Marine Launches BioFA Anti-Aging Ingredient II-39

5. RECENT INDUSTRY ACTIVITY II-41
DSM Acquires Martek II-41
Ashland Acquires ISP II-41
Aqua Bio Technology Inks Supply Agreement with Bioforskning II-41
Aquapharm Biodiscovery Signs Licensing and Collaboration
Agreement with Croda II-42
AsiaPharm and GlycoMar Sign R&D Agreement II-42
Aquatic Eco-Systems Acquires Marine Biotech II-42
Dr. Reddy's Laboratories and Aquapharm Biodiscovery Ink
Licensing Agreements II-42
Aker BioMarine Merges with Natural ASA to Form Aker BioMarine II-43
Aker BioMarine Joins Hands with Pronova Biocare II-43
ABL Biotech to Establish New R&D Facility II-43
Aquapharm Strikes an Agreement with DowpharmaSM II-43
MMRC and Nereus Pharmaceuticals to Initiate Clinical Trials
for NPI-0052 II-43
CP Kelco Acquires Gold Millet II-43
Oman’s Attempt To Excel in Marine Research II-44
Marical Inks an Agreement with ACD II-44
PharmaMar Conducts Clinical Testing of Zalypsis ® Anti-tumor
Agent II-44
CP Kelco Merges with Noviant II-44
Marine Institute, Biotrove, and NUI’S Cooperative Research on
Atlantic Salmon II-45
Jinghua Marine Biological Merges with Work Recovery II-45
Albany Molecular Research and Alcon Research in Partnership II-45
Maryland-Israel Marine Biotechnology Research Program Gains
Extension II-45
India to Set Up New National Institutions II-46
European Centre for Marine Biotechnology Inaugurated II-46
Diversa Collaborates with OSU II-46
PharmaMar Commences Phase I Clinical Trials of PM02734 II-46
USFDA Confers Orphan Drug Status to PharmaMar’s Ovarian Cancer
Drug, YONDELIS® II-46
PharmaMar Undertakes Phase II Clinical Trials of Aplidin ® for
Bladder and Prostate Cancers II-46
CorMatrix and Cook Biotech Enter into Research Agreement II-47
Elan Corp Receives European Approval for PRIALT™ (Ziconotide) II-47

6. FOCUS ON SELECT PLAYERS II-48
Aker BioMarine ASA (Norway) II-48
Ashland Inc (US) II-48
CP Kelco US, Inc. (US) II-48
Cyanotech Corp. (US) II-48
Elan Corporation, plc (Ireland) II-49
FMC Corp. (US) II-49
FMC Biopolymers AS (Norway) II-49
GlycoMar Ltd. (UK) II-49
Lonza Group Ltd (Switzerland) II-50
MariCal (US) II-50
Marinova (Australia) II-50
Mera Pharmaceuticals Inc (US) II-51
New England Biolabs Inc (US) II-51
PharmaMar S.A (Spain) II-51
PML Applications Ltd. (UK) II-51
Prolume Ltd (US) II-52
Royal DSM N.V (Netherlands) II-52
Sea Run Holdings, Inc. (US) II-52
Tequesta Marine Biosciences (US) II-53

7. GLOBAL MARKET PERSPECTIVE II-54
Table 1: World Recent Past, Current & Future Analysis for
Marine Biotechnology by Geographic Region - US and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2009 through 2017(includes
corresponding Graph/Chart) II-54

Table 2: World Historic Review for Marine Biotechnology by
Geographic Region -US and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) II-55

Table 3: World 15-Year Perspective for Marine Biotechnology by
Geographic Region- Percentage Breakdown of Dollar Sales for US
and Rest of World Markets for Years 2003, 2011 & 2017
(includes corresponding Graph/Chart) II-56

Table 4: World Recent Past, Current & Future Analysis for
Marine Biotechnology by Product Segment- Marine Biomaterials,
Marine Bioactive Substances, and Others Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2009 through 2017 (includes corresponding Graph/Chart) II-57

Table 5: World Historic Review for Marine Biotechnology by
Product Segment - Marine Biomaterials, Marine Bioactive
Substances, and Others Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2003 through
2008 (includes corresponding Graph/Chart) II-58

Table 6: World 15-Year Perspective for Marine Biotechnology by
Product Segment - Percentage Breakdown of Dollar Sales for
Marine Biomaterials, Marine Bioactive Substances and Others
Markets for Years 2003, 2011 & 2017 (includes corresponding
Graph/Chart) II-59

Table 7: World Recent Past, Current & Future Analysis for
Marine Biotechnology by End-use Application-Industrial
Products, Health Care/Biotechnology, Consumer Products, Public
Services and Infrastructure and Other Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2009 through 2017 (includes corresponding Graph/Chart) II-60

Table 8: World Historic Review for Marine Biotechnology by
End-Use Application- Industrial Products, Health Care/
Biotechnology, Consumer Products, Public Services and
Infrastructure and Others Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2003 through
2008 (includes corresponding Graph/Chart) II-61

Table 9: World 15-Year Perspective for Marine Biotechnology by
End-Use Application- Percentage Breakdown of Dollar Sales for
Industrial Products, Health Care/ Biotechnology, Consumer
Products, Public Services and Infrastructure and Other Markets
for Years 2003, 2011 & 2017 (includes corresponding
Graph/Chart) II-62


III. COMPETITIVE LANDSCAPE

Total Companies Profiled: 87 (including Divisions/Subsidiaries - 95)

------------------------------------------
Region/Country Players
------------------------------------------
The United States 31
Canada 4
Japan 1
Europe 37
France 1
Germany 4
The United Kingdom 7
Spain 1
Rest of Europe 24
Asia-Pacific (Excluding Japan) 20
Middle-East 2
------------------------------------------